ChiCTR2200055418
Untitled Trial
Analysis of viral transcriptional activity of chronic hepatitis B in different HBeAg infection states and prediction of drug withdrawal safety
Dongzhimen Hospital, Beijing University of Chinese Medicine·Phase 1·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Hepatitis B
Sponsor & location
- Primary sponsor
- Dongzhimen Hospital, Beijing University of Chinese Medicine
- Funder
- Special funds for basic scientific research business expenses of central colleges and universities of Beijing University of Traditional Chinese Medicine
- Location
- China
Timeline & enrollment
- Phase
- Phase 1
- Start date
- N/A
- End date
- Dec 31, 2022
ICD-10 classifications
Acute hepatitis BAcute hepatitis B without delta-agent and without hepatic comaAcute delta-(super)infection in chronic hepatitis BChronic viral hepatitis B without delta-agentChronic viral hepatitis B without delta-agent : other and unspecified phase
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200055418
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200055418 through Pure Global AI's free database. This Phase 1 trial is sponsored by Dongzhimen Hospital, Beijing University of Chinese Medicine and is currently Recruiting. The study focuses on Hepatitis B.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.